Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunqian Yang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cellular & Molecular Immunology|May 20, 2026
Adaptive resistance in cancer immunotherapyKe Yang, Chunqian Yang, Kai Xiong, et al.
Cell Death Discovery|April 8, 2025
VANGL2 downregulates HINT1 to inhibit the ATM-p53 pathway and promote cisplatin resistance in small cell lung cancerJiayi Xie, Huiying Liu, Chunqian Yang, et al.
Clinical and Experimental Medicine|June 22, 2024
Long non-coding RNAs in ferroptosis and cuproptosis impact on prognosis and treatment in hepatocellular carcinomaKun Wang, Chunqian Yang, Jingen Xie, et al.
Discover Oncology|February 10, 2025
Development of a novel prognostic signature based on cytotoxic T lymphocyte-evasion genes for hepatocellular carcinoma patient managementQinmei Zhu, Shiping Liao, Ting Wei, et al.
Cancer Reports (Hoboken, N.J.)|July 8, 2025
Comparison of Random Survival Forest Based-Overall Survival With Deep Learning and Cox Proportional Hazard Models in HER-2-Positive HR-Negative Breast CancerWenqi Cai, Yan Qi, Linhui Zheng, et al.
Computational and Structural Biotechnology Journal|August 8, 2025
Integrative machine learning approach for forecasting lung cancer chemosensitivity: From algorithm to cell line validationJinghong Chen, Yonglin Yi, Chunqian Yang, et al.
Cell Communication and Signaling : CCS|March 21, 2025
Cancer‑associated fibroblasts: a pivotal regulator of tumor microenvironment in the context of radiotherapyLinhui Zheng, Wenqi Cai, Yuan Ke, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 28, 2023
Optimal treatment strategy and prognostic analysis for hypopharyngeal squamous-cell carcinoma patients with T3-T4 or node-positive: A population-based studyLinhui Zheng, Sha Fang, Linfeng Ye, et al.
Cell Death & Disease|June 5, 2026
The CDK4/6 inhibitor dalpiciclib augments the antitumor efficacy of enzalutamide in preclinical models of castration-resistant prostate cancer through inhibition of MCM4-mediated DNA replicationYue Liu, Yuan Ke, Jingtian Yu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cellular & Molecular Immunology|May 20, 2026
Adaptive resistance in cancer immunotherapyKe Yang, Chunqian Yang, Kai Xiong, et al.
Cell Death Discovery|April 8, 2025
VANGL2 downregulates HINT1 to inhibit the ATM-p53 pathway and promote cisplatin resistance in small cell lung cancerJiayi Xie, Huiying Liu, Chunqian Yang, et al.
Clinical and Experimental Medicine|June 22, 2024
Long non-coding RNAs in ferroptosis and cuproptosis impact on prognosis and treatment in hepatocellular carcinomaKun Wang, Chunqian Yang, Jingen Xie, et al.
Discover Oncology|February 10, 2025
Development of a novel prognostic signature based on cytotoxic T lymphocyte-evasion genes for hepatocellular carcinoma patient managementQinmei Zhu, Shiping Liao, Ting Wei, et al.
Cancer Reports (Hoboken, N.J.)|July 8, 2025
Comparison of Random Survival Forest Based-Overall Survival With Deep Learning and Cox Proportional Hazard Models in HER-2-Positive HR-Negative Breast CancerWenqi Cai, Yan Qi, Linhui Zheng, et al.
Computational and Structural Biotechnology Journal|August 8, 2025
Integrative machine learning approach for forecasting lung cancer chemosensitivity: From algorithm to cell line validationJinghong Chen, Yonglin Yi, Chunqian Yang, et al.
Cell Communication and Signaling : CCS|March 21, 2025
Cancer‑associated fibroblasts: a pivotal regulator of tumor microenvironment in the context of radiotherapyLinhui Zheng, Wenqi Cai, Yuan Ke, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 28, 2023
Optimal treatment strategy and prognostic analysis for hypopharyngeal squamous-cell carcinoma patients with T3-T4 or node-positive: A population-based studyLinhui Zheng, Sha Fang, Linfeng Ye, et al.
Cell Death & Disease|June 5, 2026
The CDK4/6 inhibitor dalpiciclib augments the antitumor efficacy of enzalutamide in preclinical models of castration-resistant prostate cancer through inhibition of MCM4-mediated DNA replicationYue Liu, Yuan Ke, Jingtian Yu, et al.
Pageof 1